Hasil Pencarian - Hossein Panjideh

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478

    Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins<... oleh Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861

    Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861 oleh Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies

    Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies oleh Hendrik Fuchs, Nicole Niesler, Alexandra Trautner, Simko Sama, Gerold Jerz, Hossein Panjideh, Alexander Weng

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5

    Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5 oleh Frank Breitling, Gerhard Moldenhauer, Antonio Pezzutto, Oliver Schmetzer, Martin Lipp, Saskia Meyer, Regina Fertig, Hossein Panjideh, Dorothée Deppe, Sandra Lüttgau

    Diterbitkan 2013-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: